MYCOF Mydecine Innovations Group Inc.Stock Price & Overview
$0.09-0.0006 (-0.69%)3:30 PM 12/01/23
Pink Current Info | $USD | Market Close
Charts
Quant Ranking
Analysis
News
Latest Headlines
People Also Follow
Company Profile
Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.